Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenguan Holdings is the world’s leading manufacturer of edible collagen sausage casings and has expanded into collagen-based food products, skincare, and polymer collagen medical biomaterials. In 2024–2025, it launched new product lines in all segments. Its medical biomaterial pipeline includes Class III device candidates such as bone fillers and oral sponges entering or preparing for clinical trials[1][4]. The company’s proprietary technology achieves high-purity medical-grade collagen exceeding FDA standards[1].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenguan Holdings.